These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38062943)

  • 21. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus.
    Isaacs D; Dickson H; O'Callaghan C; Sheaves R; Winter A; Moxon ER
    Arch Dis Child; 1991 Feb; 66(2):227-31. PubMed ID: 2001109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.
    Resch B
    Hum Vaccin Immunother; 2017 Sep; 13(9):2138-2149. PubMed ID: 28605249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of bovine respiratory syncytial virus infection and clinical disease by vaccination.
    Verhoeff J; van Nieuwstadt AP
    Vet Rec; 1984 Nov; 115(19):488-92. PubMed ID: 6097014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WITHDRAWN: Immunoglobulin for preventing respiratory syncytial virus infection.
    Wang EE; Tang NK
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001725. PubMed ID: 17636681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin for preventing respiratory syncytial virus infection.
    Wang EE; Tang NK
    Cochrane Database Syst Rev; 2000; (2):CD001725. PubMed ID: 10796658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory syncytial virus vaccine development.
    Kahn JS
    Curr Opin Pediatr; 2000 Jun; 12(3):257-62. PubMed ID: 10836163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections.
    Weil-Olivier C; Salisbury D; Navarro-Alonso JA; Tzialla C; Zhang Y; Esposito S; Midulla F; Tenenbaum T
    Hum Vaccin Immunother; 2023 Dec; 19(1):2209000. PubMed ID: 37193673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.
    Mufson MA; Belshe RB; Orvell C; Norrby E
    J Clin Microbiol; 1987 Aug; 25(8):1535-9. PubMed ID: 3305568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
    Lin GL; Golubchik T; Drysdale S; O'Connor D; Jefferies K; Brown A; de Cesare M; Bonsall D; Ansari MA; Aerssens J; Bont L; Openshaw P; Martinón-Torres F; Bowden R; Pollard AJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S666-S671. PubMed ID: 32702120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
    Stephens LM; Ross KA; McLellan JS; Narasimhan B; Varga SM
    J Virol; 2022 Nov; 96(22):e0150222. PubMed ID: 36314826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of palivizumab in preterm infants 29 to 32 weeks' gestational age without chronic lung disease to prevent serious respiratory syncytial virus infection.
    Groothuis JR
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):414-7. PubMed ID: 12827537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of respiratory syncytial virus infection and its effect on children with heart disease in Hong Kong: a multicentre review.
    Lee SH; Hon KL; Chiu WK; Ting YW; Lam SY
    Hong Kong Med J; 2019 Oct; 25(5):363-371. PubMed ID: 31619575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies.
    Lee Mortensen G; Harrod-Lui K
    Expert Rev Vaccines; 2022 Oct; 21(10):1523-1531. PubMed ID: 35929971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Respiratory Syncytial Virus Outbreak on an Adult Stem Cell Transplant Unit by Use of Whole-Genome Sequencing.
    Zhu Y; Zembower TR; Metzger KE; Lei Z; Green SJ; Qi C
    J Clin Microbiol; 2017 Oct; 55(10):2956-2963. PubMed ID: 28747373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
    Jefferies K; Drysdale SB; Robinson H; Clutterbuck EA; Blackwell L; McGinley J; Lin GL; Galal U; Nair H; Aerssens J; Öner D; Langedijk A; Bont L; Wildenbeest JG; Martinon-Torres F; Rodríguez-Tenreiro Sánchez C; Nadel S; Openshaw P; Thwaites R; Widjojoatmodjo M; Zhang L; Nguyen TL; Giaquinto C; Giordano G; Baraldi E; Pollard AJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S658-S665. PubMed ID: 32794560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab).
    Groothuis JR; Nishida H
    Pediatr Int; 2002 Jun; 44(3):235-41. PubMed ID: 11982888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease.
    Wang EE; Law BJ; Robinson JL; Dobson S; al Jumaah S; Stephens D; Boucher FD; McDonald J; Mitchell I; MacDonald NE
    Pediatrics; 1997 Mar; 99(3):E9. PubMed ID: 9099774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus bronchiolitis: prevention and treatment.
    Faber TE; Kimpen JL; Bont LJ
    Expert Opin Pharmacother; 2008 Oct; 9(14):2451-8. PubMed ID: 18778183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
    Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
    Frenkel LD; Gaur S; Bellanti JA
    Allergy Asthma Proc; 2023 Jul; 44(4):220-228. PubMed ID: 37236777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.